Market Place
Sourcing Support
FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea
Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of
DMF submissions in 2021: India, China continue to top filings
The year
2021 was eclipsed by the Covid-19 pandemic. In our update for the first half of 2020, we h
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Big changes at Teva; FDA approves one of the world’s costliest drugs
This week, Phispers brings you news about hefty pay packages at AstraZeneca and Mylan; FDA’s F
India steps up efforts to improve drug quality; Allergan vows to limit price hikes
This week, Phispers has two news items that demonstrate Indian government’s keenness to improv
Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs?
The year 2015 has gone down
in history as a record year for mergers and acquisitions in the pharmace
